Live Remus Pharmaceuticals Share Price Chart
O 8747
H 8747
L 8747
VOL 375
Remus Pharmaceuticals Performance
Days Range
Remus Pharmaceuticals Fundamentals
ROCE (TTM) | 21.87 |
P/E Ratio (TTM) | 143.23 |
P/B Ratio | 18.22 |
Industry P/E | 44.98 |
Debt to Equity | 0.03 |
ROE | 16.62 |
EPS (TTM) | 57.72 |
Dividend Yield | 0.02 |
Book Value | 453.64 |
Face Value | 10 |
Remus Pharmaceuticals Financials
Financials data is not available for Remus Pharmaceuticals. Please visit after some time.
About Remus Pharmaceuticals
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by ... Read More
Peer Comparison
Stocks | Market Cap (cr) | Market Price (₹) | 52 Week Low-High (₹) |
---|---|---|---|
Supriya Lifescience Ltd | ₹3,237.42 |
412 9.70 (2.41%) |
397.5 - 424 |
Celestial Biolabs Ltd | ₹4.56 |
1.75 0.00 (0.00) |
1.75 - 1.8 |
JFL Life Sciences Ltd | ₹44.98 |
40.9 0.00 (0.00) |
39.15 - 40.9 |
Procter & Gamble Health Ltd | ₹7,862.34 |
4746.95 17.75 (0.38%) |
4716.05 - 4769.95 |
Veerhealth Care Ltd | ₹41.16 |
26 0.00 (0.00) |
26 - 26 |
Popular Stocks
What's Trending
Remus Pharmaceuticals FAQs
What is the Share price of Remus Pharmaceuticals (REMUS)?
Can I buy Remus Pharmaceuticals (REMUS) shares?
How do I buy Remus Pharmaceuticals (REMUS) from Angel One?
- Direct investment: You can buy Remus Pharmaceuticals (REMUS) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Remus Pharmaceuticals (REMUS) shares.